Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1
Panfeng Tao, Jinqiao Sun, Zheming Wu, et al.
Nature (2019) Vol. 577, Iss. 7788, pp. 109-114
Closed Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee
Stuart G. Tangye, Waleed Al‐Herz, Aziz Bousfiha, et al.
Journal of Clinical Immunology (2022) Vol. 42, Iss. 7, pp. 1473-1507
Open Access | Times Cited: 840
Death by TNF: a road to inflammation
Geert Loo, Mathieu J.M. Bertrand
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 289-303
Open Access | Times Cited: 492
Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target
Lauren Mifflin, Dimitry Ofengeim, Junying Yuan
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 8, pp. 553-571
Open Access | Times Cited: 344
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)
Parimal Samir, R. K. Subbarao Malireddi, Thirumala‐Devi Kanneganti
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 342
Kinase inhibition in autoimmunity and inflammation
Ali A. Zarrin, Katherine Bao, Patrick J. Lupardus, et al.
Nature Reviews Drug Discovery (2020) Vol. 20, Iss. 1, pp. 39-63
Open Access | Times Cited: 340
Cell death
Kim Newton, Andreas Strasser, Nobuhiko Kayagaki, et al.
Cell (2024) Vol. 187, Iss. 2, pp. 235-256
Open Access | Times Cited: 312
A guide to cell death pathways
Junying Yuan, Dimitry Ofengeim
Nature Reviews Molecular Cell Biology (2023) Vol. 25, Iss. 5, pp. 379-395
Closed Access | Times Cited: 299
The Chemistry and Biology of Ferroptosis
Brent R. Stockwell, Xuejun Jiang
Cell chemical biology (2020) Vol. 27, Iss. 4, pp. 365-375
Open Access | Times Cited: 291
MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis
André L. Samson, Ying Zhang, Niall D. Geoghegan, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 278
The ‘cytokine storm’: molecular mechanisms and therapeutic prospects
Rajendra Karki, Thirumala‐Devi Kanneganti
Trends in Immunology (2021) Vol. 42, Iss. 8, pp. 681-705
Open Access | Times Cited: 272
The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues
Joshua D. Webster, Domagoj Vucic
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 243
Cell death pathways: intricate connections and disease implications
Matthias Kist, Domagoj Vucic
The EMBO Journal (2021) Vol. 40, Iss. 5
Open Access | Times Cited: 239
The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee
Stuart G. Tangye, Waleed Al‐Herz, Aziz Bousfiha, et al.
Journal of Clinical Immunology (2021) Vol. 41, Iss. 3, pp. 666-679
Open Access | Times Cited: 198
Dying cells fan the flames of inflammation
Kim Newton, Vishva M. Dixit, Nobuhiko Kayagaki
Science (2021) Vol. 374, Iss. 6571, pp. 1076-1080
Closed Access | Times Cited: 183
Mechanisms and Models of Kidney Tubular Necrosis and Nephron Loss
Francesca Maremonti, Claudia Meyer, Andreas Linkermann
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 3, pp. 472-486
Open Access | Times Cited: 143
Caspase‐8: A key protein of cross‐talk signal way in “PANoptosis” in cancer
Mingxia Jiang, Ling Qi, Lisha Li, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 7, pp. 1408-1420
Open Access | Times Cited: 134
The biochemical pathways of apoptotic, necroptotic, pyroptotic, and ferroptotic cell death
Youwei Ai, Yutong Meng, Bo Yan, et al.
Molecular Cell (2024) Vol. 84, Iss. 1, pp. 170-179
Open Access | Times Cited: 134
Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 105
Effector-Triggered Immunity
Brenna C. Remick, Moritz M. Gaidt, Russell E. Vance
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 453-481
Open Access | Times Cited: 99
The double-edged functions of necroptosis
Keng Ye, Zhimin Chen, Yanfang Xu
Cell Death and Disease (2023) Vol. 14, Iss. 2
Open Access | Times Cited: 92
Disorders of ubiquitylation: unchained inflammation
David B. Beck, Achim Werner, Daniel L. Kastner, et al.
Nature Reviews Rheumatology (2022) Vol. 18, Iss. 8, pp. 435-447
Open Access | Times Cited: 77
PANoptosis: A Cell Death Characterized by Pyroptosis, Apoptosis, and Necroptosis
Chunxia Shi, Pan Cao, Yukun Wang, et al.
Journal of Inflammation Research (2023) Vol. Volume 16, pp. 1523-1532
Open Access | Times Cited: 75
Inhibiting multiple forms of cell death optimizes ganglion cells survival after retinal ischemia reperfusion injury
Qiyu Qin, Naiji Yu, Yuxiang Gu, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 72
Cell death checkpoints in the TNF pathway
Jon Huyghe, Dario Priem, Mathieu J.M. Bertrand
Trends in Immunology (2023) Vol. 44, Iss. 8, pp. 628-643
Open Access | Times Cited: 61
Control of Cell Death in Health and Disease
Nobuhiko Kayagaki, Joshua D. Webster, Kim Newton
Annual Review of Pathology Mechanisms of Disease (2023) Vol. 19, Iss. 1, pp. 157-180
Open Access | Times Cited: 47
Page 1 - Next Page

Scroll to top